Skip to main content
TipRanks
Go Ultimate75% OFF

Neurocrine (NB3) Q2 2021 Earnings Report

0 Followers

CH:NB3 Q2 2021 EPS Results

Actual EPS
CHF 0.36
Consensus EPS
CHF 0.42
Beat/Miss
Missed by -CHF 0.06
One Year Ago EPS
CHF 0.68

CH:NB3 Q2 2021 Revenue Results

Actual Revenue
CHF 242.43M
Expected Revenue
CHF 229.24M
Beat/Miss
Beat by +CHF 13.19M
YoY Revenue Growth
-4.46%

Earnings Announcement Details

Quarter
Q2 2021
Date
08/03/2021
Time
After Close
Conference Call
Tuesday, August 3, 2021
CH:NB3 Upcoming Earnings

Neurocrine's next earnings date is estimated for February 11, 2027, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:NB3 Earnings History

CH:NB3 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 11, 20272026 (Q4)1.74-1.24――
Nov 02, 20262026 (Q3)1.601.641.71-3.92% (-0.07)
Jul 30, 20262026 (Q2)1.381.170.8931.13% (+0.28)
May 05, 20262026 (Q1)1.021.600.072287.50% (+1.54)
Feb 11, 20262025 (Q4)1.511.240.8448.00% (+0.40)
Oct 28, 20252025 (Q3)1.341.711.0464.52% (+0.67)
Jul 30, 20252025 (Q2)0.810.890.5368.25% (+0.36)
May 05, 20252025 (Q1)0.450.070.35-80.95% (-0.29)
Feb 06, 20252024 (Q4)1.350.841.21-30.56% (-0.37)
Oct 30, 20242024 (Q3)1.251.040.6951.22% (+0.35)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed